Cargando…

RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. RAB39B, a member of the Ras-oncogene superfamily, is associated with a variety of tumors. Nevertheless, the role of RAB39B in DLBCL is still unknown. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Cong, Liang, Ting, Liu, Jing, Fu, Yunfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336119/ https://www.ncbi.nlm.nih.gov/pubmed/35910358 http://dx.doi.org/10.3389/fphar.2022.931501

Ejemplares similares

Apatinib enhances chemosensitivity of ABT‐199 in diffuse large B‐cell lymphoma
por: Shi, Yuanfei, et al.
Publicado: (2022)

Rab39a and Rab39b Display Different Intracellular Distribution and Function in Sphingolipids and Phospholipids Transport
por: Gambarte Tudela, Julián, et al.
Publicado: (2019)

Clinical characterization of a novel RAB39B nonstop mutation in a family with ASD and severe ID causing RAB39B downregulation and study of a Rab39b knock down mouse model
por: Mignogna, Maria Lidia, et al.
Publicado: (2021)

Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity
por: Kuo, S-H, et al.
Publicado: (2014)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
por: Zhang, YunXiang, et al.
Publicado: (2019)

A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China
por: Yang, Chunli, et al.
Publicado: (2022)

Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation
por: Huang, Qian, et al.
Publicado: (2021)

An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment
por: Liang, Xiao-Jie, et al.
Publicado: (2021)

RAB39B Deficiency Impairs Learning and Memory Partially Through Compromising Autophagy
por: Niu, Mengxi, et al.
Publicado: (2020)

MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma
por: Leivonen, Suvi-Katri, et al.
Publicado: (2017)

Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway
por: Liu, Kaili, et al.
Publicado: (2020)

TEOA Inhibits Proliferation and Induces DNA Damage of Diffuse Large B-Cell Lymphoma Cells Through Activation of the ROS-Dependent p38 MAPK Signaling Pathway
por: Yu, Xingxing, et al.
Publicado: (2020)

RAB39B gene mutations are not linked to familial Parkinson’s disease in China
por: Kang, Ji-feng, et al.
Publicado: (2016)

Genetic Analysis of RAB39B in an Early-Onset Parkinson's Disease Cohort
por: Gao, Yujing, et al.
Publicado: (2020)

Distribution of Parkinson’s disease associated RAB39B in mouse brain tissue
por: Gao, Yujing, et al.
Publicado: (2020)

Case Report: Diffuse Large B Cell Lymphoma After Cardiac Transplantation due to Anthracycline-Induced Dilated Cardiomyopathy in Pediatric Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2022)

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma
por: Liang, Xiao-jie, et al.
Publicado: (2022)

Corrigendum: TEOA inhibits proliferation and induces DNA damage of diffuse large B-cell lymphoma cells through activation of the ROS-dependent p38 MAPK signaling pathway
por: Yu, Xingxing, et al.
Publicado: (2022)

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
por: Hammouda, Nada E., et al.
Publicado: (2017)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Mutations in RAB39B in individuals with intellectual disability, autism spectrum disorder, and macrocephaly
por: Woodbury-Smith, Marc, et al.
Publicado: (2017)

Increased level of RAB39B leads to neuronal dysfunction and behavioural changes in mice
por: Wang, Zijie, et al.
Publicado: (2023)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Diffuse Large B-Cell Lymphoma of the Cecum
por: Azad, Farhan, et al.
Publicado: (2023)

Clonally Related Plasmablastic Lymphoma Simultaneously Occurring with Diffuse Large B-Cell Lymphoma
por: Hashimoto, Norisato, et al.
Publicado: (2020)

Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma
por: Qiu, Shi, et al.
Publicado: (2022)

New agents and regimens for diffuse large B cell lymphoma
por: Wang, Liang, et al.
Publicado: (2020)

RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma
por: Peng, Hao, et al.
Publicado: (2022)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review
por: Decruyenaere, Philippe, et al.
Publicado: (2021)

Rapid identification of novel independent serum biomarkers in diffuse large B-cell lymphoma
por: Che, Yi-Qun, et al.
Publicado: (2020)

Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease
por: Lesage, Suzanne, et al.
Publicado: (2015)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Gupta, Varsha, et al.
Publicado: (2022)

PHOSPHO1 Serves as a Key Metabolism-Related Biomarker in the Tumorigenesis of Diffuse Large B-cell Lymphoma
por: Chen, Tian-rui, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1c80a090432uttp8nnib9bl8g8